News from veracyte, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2015, 09:00 ET

Veracyte, Inc. Announces $40 Million Private Placement

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it has entered into a definitive agreement to sell approximately $40 million of its common...

Apr 16, 2015, 07:30 ET

Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier to Improve Lung Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its...

Apr 14, 2015, 07:30 ET

Veracyte and GE Announce Research Collaboration

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, and GE today announced a research...

Mar 19, 2015, 16:05 ET

Veracyte, Inc. Announces Fourth Quarter and Full-Year 2014 Financial Results, Provides 2015 Financial Outlook

 Veracyte, Inc. (Nasdaq: VCYT) today reported financial results and business progress for the quarter and full year ended December 31, 2014,...

Mar 12, 2015, 07:30 ET

Veracyte, Inc. to Announce Fourth Quarter and Full-Year 2014 Financial Results and Host Conference Call and Webcast on Thursday, March 19, 2015

 Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its fourth quarter and full-year 2014 financial results after close of...

Mar 06, 2015, 07:30 ET

Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment

 Veracyte, Inc. (Nasdaq: VCYT) today announced new data demonstrating that diagnostic tests that use increasing numbers of cancer-associated...

Feb 23, 2015, 07:30 ET

Veracyte to Present at the Cowen and Company 35th Annual Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Cowen and...

Feb 05, 2015, 07:30 ET

Veracyte Announces Publication of Data Demonstrating Analytical and Clinical Validity of Its Afirma® BRAF Malignancy Classifier

 Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of data demonstrating the analytical and clinical validity of Afirma®...

Feb 04, 2015, 07:30 ET

Veracyte to Present at the Leerink Partners 2015 Global Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present in a fireside chat...

Jan 12, 2015, 07:30 ET

Veracyte, Inc. Names Dr. Robert S. Epstein to Its Board of Directors

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointment of...

Jan 08, 2015, 07:30 ET

Veracyte to Present at the J.P. Morgan 33rd Annual Healthcare Conference

Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the J.P. Morgan 33rd...

Dec 02, 2014, 07:30 ET

Veracyte Announces Positive Coverage Policy for Afirma® Gene Expression Classifier from Blue Shield of California

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced today that Blue Shield of...

Nov 24, 2014, 07:39 ET

Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present in a fireside chat...

Nov 13, 2014, 16:05 ET

Veracyte, Inc. Announces Third Quarter 2014 Financial Results

 Veracyte, Inc. (Nasdaq: VCYT) today reported financial results for the third quarter ended September 30, 2014 and provided an update on...

Nov 12, 2014, 07:30 ET

Veracyte Announces Appointment of John L. Bishop to Its Board of Directors Following the Resignation of Samuel D. Colella

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced the resignation of Samuel...

Nov 06, 2014, 07:30 ET

Veracyte, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2014 Financial Results on November 13, 2014

Veracyte, Inc. (Nasdaq: VCYT) announced today that its third quarter 2014 financial results will be released after close of market on...

Oct 29, 2014, 07:30 ET

Veracyte, Inc. Announces New Data Supporting Clinical Validity of Afirma® Gene Expression Classifier

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced new data from two...

Oct 02, 2014, 07:30 ET

Veracyte Inc. to Host Investor Day on October 9, 2014

 Veracyte Inc. (Nasdaq: VCYT) today announced that the company will host a live webcast in conjunction with its Investor Day on Thursday,...

Sep 17, 2014, 07:30 ET

Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer

Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the promotion of...

Sep 04, 2014, 16:30 ET

Veracyte, Inc. to Acquire Allegro Diagnostics, Accelerating Entry Into Pulmonology Market

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to...